Global Tuberculosis (TB) Diagnostics Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Tuberculosis (TB) Diagnostics market size will reach 3,229.33 Million USD in 2025 and is projected to reach 4,444.96 Million USD by 2032, with a CAGR of 4.67% (2025-2032). Notably, the China Tuberculosis (TB) Diagnostics market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Tuberculosis (TB) diagnostics encompass a range of tests and methods aimed at identifying and confirming the presence of tuberculosis infection in individuals. One of the primary diagnostic tools is the tuberculin skin test (TST) or Mantoux test, which assesses the immune response to the tuberculosis bacterium. Additionally, molecular tests, such as nucleic acid amplification tests (NAATs) and polymerase chain reaction (PCR) assays, allow for the detection of Mycobacterium tuberculosis DNA in clinical samples. Chest X-rays are often employed to visualize lung abnormalities associated with active TB. More recently, interferon-gamma release assays (IGRAs) have been developed to measure the immune response to specific TB antigens. Culturing of samples, typically sputum, can definitively confirm the presence of the bacteria. TB diagnostics play a critical role in early detection, treatment initiation, and the overall management of tuberculosis, a contagious infectious disease that poses significant global health challenges.
The major global suppliers of Tuberculosis (TB) Diagnostics include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Tuberculosis (TB) Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Tuberculosis (TB) Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Tuberculosis (TB) Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Tuberculosis (TB) Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Tuberculosis (TB) Diagnostics Include:
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Tuberculosis (TB) Diagnostics Product Segment Include:
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Tuberculosis (TB) Diagnostics Product Application Include:
Diagnostic Laboratories
Hospitals
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Tuberculosis (TB) Diagnostics Industry PESTEL Analysis
Chapter 3: Global Tuberculosis (TB) Diagnostics Industry Porter's Five Forces Analysis
Chapter 4: Global Tuberculosis (TB) Diagnostics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Tuberculosis (TB) Diagnostics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Tuberculosis (TB) Diagnostics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Tuberculosis (TB) Diagnostics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Tuberculosis (TB) Diagnostics market size will reach 3,229.33 Million USD in 2025 and is projected to reach 4,444.96 Million USD by 2032, with a CAGR of 4.67% (2025-2032). Notably, the China Tuberculosis (TB) Diagnostics market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Tuberculosis (TB) diagnostics encompass a range of tests and methods aimed at identifying and confirming the presence of tuberculosis infection in individuals. One of the primary diagnostic tools is the tuberculin skin test (TST) or Mantoux test, which assesses the immune response to the tuberculosis bacterium. Additionally, molecular tests, such as nucleic acid amplification tests (NAATs) and polymerase chain reaction (PCR) assays, allow for the detection of Mycobacterium tuberculosis DNA in clinical samples. Chest X-rays are often employed to visualize lung abnormalities associated with active TB. More recently, interferon-gamma release assays (IGRAs) have been developed to measure the immune response to specific TB antigens. Culturing of samples, typically sputum, can definitively confirm the presence of the bacteria. TB diagnostics play a critical role in early detection, treatment initiation, and the overall management of tuberculosis, a contagious infectious disease that poses significant global health challenges.
The major global suppliers of Tuberculosis (TB) Diagnostics include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Tuberculosis (TB) Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Tuberculosis (TB) Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Tuberculosis (TB) Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Tuberculosis (TB) Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Tuberculosis (TB) Diagnostics Include:
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Tuberculosis (TB) Diagnostics Product Segment Include:
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Tuberculosis (TB) Diagnostics Product Application Include:
Diagnostic Laboratories
Hospitals
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Tuberculosis (TB) Diagnostics Industry PESTEL Analysis
Chapter 3: Global Tuberculosis (TB) Diagnostics Industry Porter's Five Forces Analysis
Chapter 4: Global Tuberculosis (TB) Diagnostics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Tuberculosis (TB) Diagnostics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Tuberculosis (TB) Diagnostics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Tuberculosis (TB) Diagnostics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Tuberculosis (TB) Diagnostics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Tuberculosis (TB) Diagnostics Product by Type
- 1.2.1 Culture-Based Diagnostics
- 1.2.2 Sputum Smear Microscopy
- 1.2.3 Rapid Molecular Diagnostics
- 1.2.4 Others
- 1.3 Tuberculosis (TB) Diagnostics Product by Application
- 1.3.1 Diagnostic Laboratories
- 1.3.2 Hospitals
- 1.4 Global Tuberculosis (TB) Diagnostics Market Size Analysis (2020-2032)
- 1.5 Tuberculosis (TB) Diagnostics Market Development Status and Trends
- 1.5.1 Tuberculosis (TB) Diagnostics Industry Development Status Analysis
- 1.5.2 Tuberculosis (TB) Diagnostics Industry Development Trends Analysis
- 2 Tuberculosis (TB) Diagnostics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Tuberculosis (TB) Diagnostics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Tuberculosis (TB) Diagnostics Market Analysis by Country
- 4.1 Global Tuberculosis (TB) Diagnostics Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Tuberculosis (TB) Diagnostics Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Tuberculosis (TB) Diagnostics Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.5 China Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.6 France Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.14 India Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Tuberculosis (TB) Diagnostics Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Tuberculosis (TB) Diagnostics Market Revenue by Key Suppliers (2021-2025)
- 5.2 Global Tuberculosis (TB) Diagnostics Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Tuberculosis (TB) Diagnostics Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Tuberculosis (TB) Diagnostics Market Analysis by Type
- 6.1 Global Tuberculosis (TB) Diagnostics Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Tuberculosis (TB) Diagnostics Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Danaher
- 7.1.1 Danaher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
- 7.1.3 Danaher Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Roche
- 7.2.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Roche Tuberculosis (TB) Diagnostics Product Portfolio
- 7.2.3 Roche Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Thermo Fisher Scientific
- 7.3.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
- 7.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 BD
- 7.4.1 BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 BD Tuberculosis (TB) Diagnostics Product Portfolio
- 7.4.3 BD Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Abbott
- 7.5.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
- 7.5.3 Abbott Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Hologic
- 7.6.1 Hologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
- 7.6.3 Hologic Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Qiagen
- 7.7.1 Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
- 7.7.3 Qiagen Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 BioMerieux
- 7.8.1 BioMerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
- 7.8.3 BioMerieux Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Hain Lifescience
- 7.9.1 Hain Lifescience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
- 7.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Oxford Immunotec
- 7.10.1 Oxford Immunotec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
- 7.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Tuberculosis (TB) Diagnostics Industry Chain Analysis
- 8.2 Tuberculosis (TB) Diagnostics Product Downstream Application Analysis
- 8.2.1 Global Tuberculosis (TB) Diagnostics Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Tuberculosis (TB) Diagnostics Revenue and Forecast by Application (2020-2032)
- 8.3 Tuberculosis (TB) Diagnostics Typical Downstream Customers
- 8.4 Tuberculosis (TB) Diagnostics Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
